Ovid Therapeutics (OVID) Surges on New Buy Rating

September 4, 2019 8:57 AM EDT Send to a Friend

Ovid Therapeutics (NASDAQ: OVID) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Ovid Therapeutics (OVID) Surges on New Buy Rating

Member Login

Free News Feed